Zhengye Biotechnology Holding Limited

US$1.50As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ZYBTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (25.17%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) —
PE TTM —
TSR TTM (39.02%)
Mkt cap US$71.09M
ROIC (21.37%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.83
22.25%
(90.53%)
Buy 12|2|1|12|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.02
0.02
0.02
0.02
10.71%
6.25%
7.50%
19.11%
Revenue¥M
5.159
5.337
5.542
5.464
3.00%
3.32%
4.68%
2.87%
Peers (US$71.09M)
Cap (US$)
PE
110.2M
—
Capital
TTM
5Y
10Y
Leveragex
1.545
(0.195)
(0.134)
EBIT/Intx
0.098
3.476
2.555
Own earn%
16.55
253.93
252.58
Sh yield%
14.47
27.20
29.78
Owners
Insiders/Inst%
1.14
69.11
Short interest%
0.55
SBC / revenue%
2.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
18–24
$1 testx
—
Incr. ROIC%
11